Company Overview
Snapshot
Founded in June 1990 by Udi Gafni, Medoc operates with 51–200 employees. The company specializes in neurodiagnostic medical systems for pain assessment and monitoring, holding patents for rapid pain stimulation technology.
Business overview
Medoc develops and manufactures neurodiagnostic medical systems designed for assessing and monitoring acute and chronic pain. The company's core technology leverages quantitative sensory testing techniques to evaluate peripheral sensory nerve fibers, providing noninvasive and painless diagnostic capabilities. These systems are integrated into user-friendly, cost-effective platforms for research and clinical environments. Medoc serves various disciplines within the healthcare and life sciences sectors, including pharmaceutical research, clinics, and laboratories, with products that are FDA approved, CSA certified, and CE marked.
Log in to access full profile ›Company Intelligence Q&A
- What is Medoc's primary focus?
- Medoc specializes in developing and manufacturing neurodiagnostic medical systems for the assessment and monitoring of acute and chronic pain.
- What kind of technology does Medoc utilize in its products?
- Medoc's products are based on technologies that test and evaluate the function of small and large peripheral sensory nerve fibers, utilizing quantitative sensory testing techniques.
- What certifications and approvals do Medoc's products hold?
- All of Medoc's products are FDA approved, certified by CSA, and CE marked to the EN-60601-1 International Safety Standard.
- What is the strategic significance of Medoc's patented technology?
- Medoc's patented rapid pain stimulation technology has facilitated new developments in areas such as functional MRI, pharmaceutical research, and other pain-related treatments and testing modalities.
- When was Medoc founded and by whom?
- Medoc was founded in June 1990 by Udi Gafni.